Moneycontrol PRO
HomeNewsBusinessStocksSaakshi Medtech shares locked at upper circuit on winning order worth Rs 250 crore

Saakshi Medtech shares locked at upper circuit on winning order worth Rs 250 crore

The share touched a 52-week high of Rs 369.00 and a 52-week low of Rs 176.05 on 04 July, 2024 and 27 November, 2024, respectively.

December 11, 2024 / 09:24 IST
Saakshi Medtech

Saakshi Medtech

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Saakshi Medtech and Panels share price locked ta upper circuit on December 11 following the company received Letter of Business Award (LoBA) from Mahindra & Mahindra for supply of EV panels including three years Guarantee/ Warranty.

At 09:21am, Saakshi Medtech & Panels was quoting at Rs 220.05, up Rs 20, or 10 percent, on the NSE.

There were pending buy orders of 264,000 shares, with no sellers available.

The total amount of the order value is for around Rs 250 crore (inclusive of GST) for period of five years (till 2029) and to be completed within 60 days.

Catch all the market action on our live blog

The company in the quarter ended September 2024 reported profit of Rs 3.45 crore.

The share touched a 52-week high of Rs 369.00 and a 52-week low of Rs 176.05 on 04 July, 2024 and 27 November, 2024, respectively.

Currently, the stock is trading 40.37 percent below its 52-week high and 24.99 percent above its 52-week low.

Moneycontrol News
first published: Dec 11, 2024 07:33 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347